EP Wealth Advisors LLC Has $36.22 Million Position in HCA Healthcare, Inc. $HCA

Key Points

• EP Wealth Advisors LLC reduced its holdings in HCA Healthcare, Inc. by 29.6% in the first quarter, now owning 104,811 shares valued at approximately $36.22 million.
• HCA Healthcare reported earnings of $6.84 EPS for the last quarter, exceeding analysts' expectations by $0.64, and set its FY 2025 guidance between 25.500-27.000 EPS.
• The company announced a quarterly dividend of $0.72 per share, representing an annualized dividend yield of 0.7%, with the payment set for September 30th.

EP Wealth Advisors LLC trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 29.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 104,811 shares of the company's stock after selling 44,035 shares during the period. EP Wealth Advisors LLC's holdings in HCA Healthcare were worth $36,217,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Cheviot Value Management LLC purchased a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. Saudi Central Bank purchased a new stake in shares of HCA Healthcare in the first quarter valued at $26,000. WPG Advisers LLC acquired a new stake in shares of HCA Healthcare during the first quarter valued at $27,000. Atwood & Palmer Inc. purchased a new stake in HCA Healthcare in the 1st quarter worth approximately $28,000. Finally, Bartlett & CO. Wealth Management LLC increased its position in HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on HCA shares. Barclays lowered their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a report on Monday, July 28th. Wells Fargo & Company decreased their target price on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a research report on Thursday, August 14th. Stephens raised HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Finally, Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $9.09 during mid-day trading on Friday, reaching $420.68. 1,059,770 shares of the stock were exchanged, compared to its average volume of 1,538,335. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $420.98. The company has a market cap of $98.43 billion, a price-to-earnings ratio of 17.68, a price-to-earnings-growth ratio of 1.28 and a beta of 1.41. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The firm has a 50-day simple moving average of $379.31 and a 200 day simple moving average of $359.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same period last year, the firm earned $5.50 EPS. The business's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.